Tagged with R

biotech The general manager in charge of Mexico, Central America and the Caribbean is on board with the corporate mission of doubling Shire’s product sales to USD 10 billion by 2020 and explains how Mexico and the rest of the region will contribute to this achievement. You were appointed head of…

oncology In the Mexican pharmaceutical industry change is the name of the game. The general director of Pierre Fabre Mexico and Central America expands on how the company has adapted its go-to-market strategy and has succeeded in positioning itself as a top player in women’s health and primary care, lead by…

clinical research The general director of the National Institute for Psychiatry discusses the Institute’s commitment to translating clinical research into better care for patients, the social stigma patients with mental disorders still face in Mexico and the increasing importance of mental health on productivity and the country’s economic development. You have been…

R&D James Jun, CEO of KT&G Life Sciences, discusses his company’s new entry into the Korean pharma market and the role that the KT&G brand can play in accelerating its drug development process. How did KT&G Life Sciences begin, and what was the reasoning behind starting this company in the first…

investment Johannes Hauser, managing director of the German-Mexican Chamber of Commerce explains the role of the chamber in Mexico and encourages small and medium-sized companies in Germany to consider the country as a destination to expand their business. The German-Mexican Chamber of Commerce dates back to 1929. What are the Chamber’s…

R&D The first woman appointed as general director of one of the leading neurosciences institutions in Latin America discusses the Institute’s priorities in terms of R&D for brain diseases, training of high-specialty medical professionals and the increasing trend towards “feminization of medicine” in Mexico. You were appointed general director of the…

manufacturing The CEO recounts the rise of one of Algeria’s home grown success stories, analyses the future of the local para-pharmaceutical market and explains how attitudes and customs are changing with issues like adult incontinence no longer taboo topics. Can you introduce FADERCO, its evolution, investments and achievements to date? FADERCO’s…

pharmaceuticals The CEO narrates the historic role that the company has played in kickstarting the Algerian home-grown pharmaceuticals industry and outlines ambitious joint venture projects that seek to have a transformative effect on the local sector. Mr. Derkaoui, can you please start by introducing yourself and telling us a little bit…

manufacturing The country manager for Algeria discusses how the company was the first foreign entity to engage in local manufacturing and sheds light on some of the difficulties in introducing innovative molecules to the market. Pfizer was one of the first multinationals to engage with the Algerian pharmaceuticals market and enjoys…

research Genomic medicine is gaining momentum. The general director of the institute founded in 2004 explains how genomics is helping unlocking the secret codes, which will help understand and treat pathologies affecting the Mexican population such as diabetes. What have been the three main priorities of the Institute since you took…

distribution For 40 years Apotex has made providing patients around the globe with access to quality and affordable medicines its priority. The general director for Northern Latin America discusses the importance of Mexico as Apotex’ fourth market worldwide and gatekeeper to the rest of Latin America, as well as the company’s…

regulatory Santiago Garcia Belmonte, president of Biosidus, discusses how global regulatory trends are driving change in the Argentinian biotech industry, as well the new direction his firm has taken over the last five years. How would you describe the recent changes in the biotech market and the industries new direction? Things…